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Fusion positron emission and computed tomography (PET/CT) remains the gold-standard
imagingmodality to non-invasively studymetabolically active brown adipose tissue (BAT). It
has been widely applied to studies in adult cohorts. In contrast, the number of BAT studies
in children has been few.This is largely limited by the elevated risk of ionizing radiation and
radionuclide tracer usage by PET/CT and the ethical restriction of performing such exams
on healthy children. However, metabolically active BAT has a signiﬁcantly higher prevalence
in pediatric patients, according to recent literature. Young cohorts thus represent an ideal
population to examine the potential relationships of BAT to muscle development, puberty,
disease state, and the accumulation of white adipose tissue. In turn, magnetic resonance
imaging (MRI) represents the most promising modality to overcome the limitations of
PET/CT.The development of rapid, repeatable MRI techniques to identify and quantify both
metabolically active and inactive BAT non-invasively and without the use of exogenous con-
trast agents or the need for sedation in pediatric patients are critically needed to advance
our knowledge of this tissue’s physiology.
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INTRODUCTION
The recent ﬁndings of metabolically active brown adipose tissue
(BAT) in adult humans by fusion positron emission and com-
puted tomography (PET/CT) have reinvigorated research toward
the tissue’s role in energy balance, metabolism, and physiology
(Cypess et al., 2009; van Marken Lichtenbelt et al., 2009; Virta-
nen et al., 2009). In contrast to white adipose tissue (WAT), which
functions to store fat and consists of cells with large intracellu-
lar lipid droplets, BAT is involved in lipid metabolism and both
non-shivering and diet-induced thermogenesis, facilitated by its
unique uncoupling protein UCP-1 (Rothwell and Stock, 1979;
Himms-Hagen, 1989). BAT is also highly vascularized, rich in
mitochondria organelles, innervated by the sympathetic nervous
system, andmost importantly, it is metabolically active and preva-
lent in newborns and children (Heaton, 1972; Enerback, 2010). In
contrast toWAT adipocytes, brown adipocytes are further charac-
terized by multiple smaller intracellular lipid droplets, have lower
lipid content by volume, and greater intracellular water (Cannon
and Nedergaard, 2004; Cinti, 2006).
While fusion PET/CT has provided the unique ability to non-
invasively visualize metabolically active BAT and remains the
gold-standard approach, it is now recognized by the scientiﬁc
community that PET/CT lacks sensitivity and speciﬁcity, has key
limitations, and that new and alternative imaging techniques need
to be developed. First, PET/CT is restricted to oncology patients as
a tool for tumor detection and cancer screening. Second, PET/CT
is not widely applicable to the general population due to signiﬁ-
cant radiation exposures, the need to inject a radionuclide tracer,
and related prohibitive costs. It is also not suited for longitudinal
studies where repeated scans are required. Third, PET/CT can
only detect metabolically active BAT that uptakes the injected
tracer, which represents only a small percentage of the tissue’s
total amount in the body. Moreover, tracer uptake by metaboli-
cally active BAT is sensitive to factors such as environment and
examination room temperature, season, anesthesia, the amount
of clothing worn by the patient (Au-Yong et al., 2009; Pfannen-
berg et al., 2010; Yoneshiro et al., 2011), and the health/disease
condition of the subject at exam time. The presence of metabol-
ically active BAT can further be confounded by competing tracer
uptake in nearbymuscles, organs, and tumors. Perhaps the biggest
unmet need in the imaging of BAT by PET/CT is that the endpoint
measurement remains a binary visual interpretation of positive or
negative depiction of BAT activity, often decided by the reading
radiologist. This subjective measure has made systematic compar-
isons between studies from various investigators difﬁcult with no
apparent consensus amongst the literature.Ultimately, themethod
lacks the ability to generate a quantitative measure of total BAT
mass or volume, one however that is critically needed to advance
the ﬁeld. Alternatives such as standalone CT and magnetic reso-
nance imaging (MRI) that can detect BAT based on morphology,
regardless of tissue metabolic activity, are necessary to avoid the
confounding factors that have limited functional PET/CT.
In this review article, we ﬁrst survey several unique imaging
signatures of BAT that differentiates this tissue from WAT in CT
and MRI based solely on morphology. These have been published
in recent imaging periodicals. MRI holds promise as the most
appropriate non-invasive imaging modality for studying BAT in
humans, particularly in newborns and children, since it does not
www.frontiersin.org September 2011 | Volume 2 | Article 33 | 1
Hu and Gilsanz Brown adipose tissue in children
involve ionizing radiation and can be repeatedmultiple times with
ultra-low risk. In the second part of this review, we summarize the
high prevalence of BAT by PET/CT in pediatric patients and ﬁnd-
ings of BAT associations withmuscle volume, puberty, and disease
states from studies performed at our institution,Children’s Hospi-
tal of Los Angeles. Our goal is to inform the reader that (1) due to
high BAT prevalence, young cohorts represent an ideal population
to study BAT physiology and examine the relationships of BAT to
muscle development, puberty, disease states, and body adiposity,
and that (2) MRI is the most suitable platform to implement these
investigations in pediatric populations.
IMAGING OF BAT
IMAGING SIGNATURES OF BAT IN CT
In PET/CT, standard uptake values (SUVs) have been used as
an adjunct to distinguish metabolically active BAT from inactive
WAT, based on uptake of a tracer, typically ﬂuoro-deoxyglucose
(FDG). By radiology convention CT images of tissues with nega-
tive Hounsﬁeld units (HUs) X-ray attenuations have traditionally
been interpreted as fat and no additional stratiﬁcation of the neg-
ative HU scale was further considered. In contrast, all other soft
tissues and bone occupy the positive HU range. The question of
whether there exists a parallel difference in CT HUs and tissue
densities between BAT and WAT has only been recently suggested
and explored (Carter and Schucany, 2008; Baba et al., 2010; Hu
et al., 2011). These studies have found that additional stratiﬁcation
of the negative HU scale is feasible to uniquely differentiate meta-
bolically active BAT and WAT. Namely, metabolically active BAT
was characterized by higher, but still negative, HUs than lipid-rich
WAT. BAT exhibits higher CT attenuation values thanWAT, largely
due to its greater intracellular water content and higher degree of
vascularization. Figure 1A illustrates results from a cohort of pedi-
atric patients who all exhibited positive visual depiction of BAT
on their PET/CT exams (Hu et al., 2011). It is important to note
that metabolically active BAT and inert WAT data points occupy
unique and nearly non-overlapping regions on the CT HU versus
PET SUV plot. The use of standalone CT to identify and quantify
metabolically active BAT, however, has not yet been corroborated
by a large study or validated with histology. Furthermore, whether
suchHUdifferences betweenmetabolically inactive BAT andWAT
exist has yet to be explored.
IMAGING SIGNATURES OF BAT IN MRI
The use of MRI and magnetic resonance spectroscopy (MRS) to
study BAT in rodents was investigated in the 1990s (Sbarbati et al.,
1997; Lunati et al., 1999). Inspired by these early works, recent
FIGURE 1 |The difference in intracellular water and fat content
between BAT andWAT leads to unique signal contrast between
the two tissues in (A) PET/CT and (B) MRI. In (A) PET/CT,
metabolically active BAT andWAT not only differ in their standard uptake
values (SUVs) of the radionuclide tracer, but also in their Hounsﬁeld units
(HUs) of X-ray attenuation. The greater water content in BAT leads to more
positive HUs thanWAT. Note that the differences in SUVs and HUs between
the two tissues are unique, with no overlap on either axis. In (B) MRI,
separated water and fat representative images are shown in the sagittal plane
of a mouse. Shown additionally is the corresponding fat fraction (FF) map, on
a color scale from 0 to 100%. Illustrated to the far right is the fat fraction map
in the axial plane from the same animal. The red arrows point to the
triangular/trapezoidal interscapular BAT depot. The white dotted arrows
denoteWAT. Note that BAT has a much lower fat fraction thanWAT, caused by
BAT’s greater water and lower fat content, which can be observed by the
opposing grayscale contrast differences in the water and fat images,
respectively. (C) A schematic of approximate BAT andWAT signal contrasts
based on CT HU and MRI FF.
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methodological advances in both MRI and MRS methodology
have led to several promising literature publications describing
more robust and accurate characterizations of rodent BAT. Unlike
PET/CT where the functional uptake of a radionuclide tracer was
needed todifferentiateBAT fromWAT,one common theme among
these MR-based works was the use of only morphological differ-
ences between BAT andWAT for identiﬁcation and signal contrast.
Speciﬁcally, the greater vascularity, mitochondria number, and
intracellular water in closer proximity to lipid droplets of BAT
when compared to WAT have been exploited.
Using chemical-shift water–fat separationMRI techniques that
can accurately decompose lean (water-based) and fatty (lipid-
based) signals across an imaging volume on a voxel-wise basis, Hu
et al. (2010a) demonstrated in mice the feasibility of differentiat-
ing BAT andWAT based on a fat fractionmetric in wild-typemice.
A fat fractionmap was computed from the separated water and fat
signals. WhereasWAT is predominantly composed of lipids and is
thus typically characterized by a fat fraction >90%, interscapular
BAT was shown to occupy a much broader and lower fat fraction
range. Figure 1B illustrates a representative example. Figure 1C
summarizes the approximate tissue signal contrast between BAT
andWAT by CT and chemical-shift MRI. In a follow-up study, the
investigators further showed that their technique could detect dif-
ferences in BAT fat fraction among mice groups that were housed
at cold (19˚C) and warm (25˚C) temperatures. Given ad libitum
access to food,mice exposed to colder temperature consumed sig-
niﬁcantly more food (∼30%), exhibited lower BAT fat fractions
(∼10% difference), but yet maintained the similar body weight,
and composition, as determined by quantitative magnetic reso-
nance (QMR), in comparison to warm-housed animals over a
4-week period (Hu et al., 2010b). The lower BAT fat fractions of
the cold-exposed animals suggested greater metabolic activity and
involvement of the tissue in thermogenesis. One limitation of this
chemical-shift MRI approach is the need for high spatial resolu-
tion to avoid partial volume effects that can mimic BAT-like fat
fractions at fat–lean tissue boundaries.
In another recent study, Branca and Warren (2011a) reported
a novel and promising spectroscopy technique utilizing unique
intermolecular zero-quantum coherence transitions between
water and fat protons, speciﬁcally those of themethylene (–CH2–)
groups, to differentiate BAT from WAT (Branca and Warren,
2011a). The approach exploited the fact that in BAT, intracellu-
lar water and fat are in close physical vicinity to each other, and
thus gives rise to distinctive iZQC signal peaks. On the contrary, in
WAT,water, and fat are separated by greater distances and thus such
iZQC peaks are not observed. Furthermore, the authors demon-
strated that the amplitude of the signal peaks were substantially
greater in more thermogenically active young mice than in old or
obese mice, signifying increased amounts of metabolically active
BAT in the former group. However, in BAT, and WAT, iZQC sig-
nal peaks from interactions between lipid methylene and oleﬁnic
groups were both observed. The critical methodological advance-
ment was that iZQC allowed the investigators to perform a survey-
like scan and unambiguously determine whether BAT is simply
present in an imaging volume based on the tissue’s unique water–
fat signal peaks. In a related follow-up study by Branca andWarren
(2011b) the researchers used a variant of their spectroscopy tech-
nique to determine differences in the chemical composition of
adipose tissue, such as triglyceride degree of unsaturation, in mice
fed with either standard chow or fatty diets (Branca and Warren,
2011b).
In another spectroscopy study by Hamilton et al. (2011), the
authors utilized conventional high-resolution proton MRS to ﬁrst
conﬁrm the ﬁnding that BAThas a uniquely lower fat fraction than
BAT. The investigators then discovered that the T1 relaxation time
of thewater component in BATwas signiﬁcantly reduced by nearly
twofold from that inWAT. Brieﬂy, theMRI/MRS signal arises from
hydrogen protons in water and fat.When an object is placed inside
a magnetic ﬁeld, a longitudinal magnetization from the proton
ensemble is created. In an MR experiment, radiofrequency pulses
are applied repetitively to gather imaging data. The pulses excite
the longitudinal magnetization and perturb it away from equi-
librium. T1 is a tissue-speciﬁc exponential constant that describes
the rate with which the perturbedmagnetization recovers between
consecutive radiofrequency excitation. The authors speculated
that the source of this apparent T1 contrast was due to the fact
that a molecule’s T1 rate is primarily governed by its surround-
ing chemical environment. In contrast toWAT where intracellular
water is conﬁned to a small globule, water molecules in BAT are
more interspersed and in greater contact with lipids.Moreover, the
researchers were able to quantify an average number of carbon–
carbon double bonds from the MR spectra, and reported that
BAT was more saturated thanWAT, consistent with previous ﬁnd-
ings (Zingaretti et al., 2009). An extended imaging approach for
carbon–carbon double-bond mapping was also recently reported
(Bydder et al., 2011) and its application to BAT is under investiga-
tion. ThisMRS approachmay not be adequate for the independent
identiﬁcation of BAT since a priori knowledge of tissue depot loca-
tion is required.Nonetheless, the technique should serve as a useful
adjunct tool for characterizing BAT properties.
Magnetic resonance is themost appropriatemodality to address
the shortcomings of PET/CT. It involves no ionizing radiation and
requires no radionuclide tracer. It can be safely repeated multiple
times with minimal risk in healthy volunteers and is applicable
to large study populations and nearly all age groups, includ-
ing children. The works demonstrated by Hu et al. (2010a,b);
Branca and Warren (2011a,b); Hamilton et al. (2011) in identify-
ing unique BAT imaging signatures from MRI and MRS represent
the modality’s immense versatility. Their results represent exciting
new potential from the fact that none of the described MR-based
signals of BAT depend on the tissue’s metabolic functions, but
rather its intrinsic cellularmorphology.Validation and application
of these MR-based methods to humans remains an area of future
research. However, it is unlikely that a single MR-based approach
will deﬁnitively capture both metabolically active and inactive
BAT (Carter and Schucany, 2008). Many additional distinctive
features of BAT are known but have not yet been explored by MRI
and MRS. For example, BAT’s immense vasculature lends itself to
well-established MRI perfusion techniques such as arterial-spin-
labeling that can quantify local blood ﬂow.MR techniques that are
sensitive to T ∗2 relaxation as a consequence of ﬂuctuating levels of
oxy- and deoxy-hemoglobin in blood are being evaluated in BAT
by multiple investigators. Signal contrasts between BAT andWAT,
such as diffusion and targeted molecular imaging of the mito-
chondria, have not been explored. Lastly, recent advances in fusion
PET/MR also holds great promise as an additional complementary
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tool for imaging BAT andwill likely play a critical role in validating
a subset of aforementioned standalone MRI techniques in future
studies.
BAT IN PEDIATRICS
PREVALENCE OF BAT IN CHILDREN
Based on previous anatomical studies, BAT was known to be
present in all neonates but thought to be lost after infancy (Ener-
back, 2010). However, signiﬁcant amounts of metabolically active
BAT have recently been noticed in a large proportion of pediatric
patients undergoing PET/CT examinations (Celi, 2009). While
BAT is seen in similar locations in adults and children, a sig-
niﬁcantly higher prevalence of nearly 10-fold increase in BAT
depiction in pediatric PET/CT examinations (Gelfand et al., 2005;
Zukotynski et al., 2010; Gilsanz et al., 2011; Hu et al., 2011) has
been reported in comparison to the prevalence in adults (Cypess
et al., 2009). Based our own experiences, approximately 40% of
PET/CT studies in young patients depict metabolically BAT, even
when they live in warm climates and when the PET/CT exams are
performed under thermoneutral conditions (Gilsanz et al., 2011).
A previous study by Gelfand et al. (2005) found that the inci-
dence of BAT uptake in adolescents was greater than in patients
younger than 10 years. More recently, using qualitative and quan-
titative approaches to analyze PET/CT exams, Gilsanz et al. (2011)
reported a higher prevalence and signiﬁcantly greater amounts of
BAT in adolescence than during childhood. In that study, whereas
less than 20% of studies in pre-pubertal girls or boys exhibited
uptake of FDG by metabolically active BAT, more than 75% of
such studies in pubertal teenagers displayed visually identiﬁable
BAT uptake. Additionally, the volume of metabolically active BAT
measured using CTHU and PET SUVmetrics increased with ado-
lescence in both sexes. The magnitude of the increase in BAT was
substantially greater during the late stages of puberty (e.g., Tanner
stages) than during the early phases of sexual development and
was substantially higher in boys when compared to girls.
Numerous metabolic and hormonal changes occur during
puberty, including increases in the production of growth hor-
mone/growth factors, gonadotropins, and sex steroid hormones.
Variations in one or more of these important modiﬁers known to
inﬂuencemuscle development could also account for the increases
and gender dimorphism in BAT development during adolescence.
Recent data suggest that sexhormones have amarked effect onBAT
activity, with corroborating studies demonstrating that associated
receptor expression differs in cell-cultured brown adipocytes of
male and female rodents, with higher numbers of all receptor
types in male BAT (Rodriguez-Cuenca et al., 2007).
ASSOCIATION OF BAT TO DISEASE
In children, like in adults, the depiction of metabolically active
BAT by PET/CT has been reported to be dependent on a multi-
tude of physiologic and technical factors including age, sex, body
composition, FDG dose, anesthesia,modality acquisition parame-
ters, and season and temperature during examinations (Cohade
et al., 2003; Au-Yong et al., 2009; Saito et al., 2009; Lee et al.,
2010; Pfannenberg et al., 2010; Yoneshiro et al., 2011). In PET/CT
studies of adult cancer patients, the visualization of metabolically
active BAT was predominantly thought to be independent of dis-
ease status, and to date, no association has been noted between
the prevalence of BAT depiction and the presence of metastases.
One previous longitudinal investigation assessing changes in BAT
in females with breast cancer found no association between tumor
response during treatment and activation of the tissue (Rousseau
et al., 2006). At our institution, we have recently observed sev-
eral cases where a patient with a malignant lymphoma exhibited
metabolically active BAT only when evidence of the disease was
not present on the PET/CT images (Figure 2). This prompted the
speculation that the prevalence of BAT in pediatric patients with
lymphoma is greater when there is no evidence of disease than
at diagnosis. In 62 studies to date involving 30 pediatric patients
at our institution, we have found that approximately 10% of the
exams at diagnosis exhibited uptake of FDG tracer by metabol-
ically active BAT, while a signiﬁcantly higher 80% of follow-up
exams after therapeutic treatment displayed BAT when there was
no longer evidence of disease.
The mechanisms responsible for the possible suppression of
BAT activity by lymphoma are unknown. However, we speculate
that patients with malignant lymphomas have high circulating
levels of tumor necrosis factor-alpha (TNF-α; Salles et al., 1996;
FIGURE 2 | Coronal PET, and registered axial CT and fusion PET/CT of a
16-year-old male patient at baseline and 36weeks follow-up after
chemotherapy treatment. At baseline, the subject exhibits no evident
bilateral and symmetrical FDG uptake by interscapular BAT (solid arrows).
However, the presence of disease is clearly visualized by strong unilateral
FDG uptake of the enlarged cervical lymph nodes (dashed arrows). On the CT
image, note that the lymph node mass is characterized by soft-tissue-like
attenuation. At follow-up, the subject exhibits clear bilateral FDG uptake
indicative of BAT. This is conﬁrmed on the CT images which show negative
fat-like attenuation (solid arrows). In contrast, the corresponding BAT depots
on the baseline axial images do not exhibit FDG uptake. Note that the
enlarged lymph node has been successfully treated.
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Warzocha et al., 1997), a pluripotent cytokine reported to elicit a
large number of biological effects in different cell systems includ-
ing the apoptotic degeneration of brown adipocytes (Nisoli et al.,
1997). This cytotoxic effect is known to be mediated by the p55
TNF-α receptor subtype, and its deletion has been shown to
increase thermogenesis with an associated increase of uncoupling
protein-1 expression in BAT (Romanatto et al., 2009). The ﬁnding
of an apparent association between disease state and BAT depic-
tion is still at an early stage, and additional research is needed to
better establish the roles of TNF-α on BAT homeostasis.
ASSOCIATION OF BAT TO MUSCLE
Adipose and musculoskeletal tissues originate from the meso-
derm, and the prevailing model has been that a common stem
cell gives rise to WAT, BAT, bone, and muscle. In an interme-
diate developmental step, it was assumed that WAT and BAT
share a common precursor because both forms of adipose tissue
express a similar array of genes involved in triglyceride metabo-
lism. However, although it is possible to convert WAT precursors
into brown adipocyte-like cells, evidence also suggests that brown
adipocytes are developmentally close to skeletal muscle. An in vivo
study by Seale et al. (2008) indicated that some brown adipocytes
arise from the sameMyf5-expressing progenitor as skeletal muscle
cells, whereas white adipocytes did not show such commonal-
ity. Consistent with this notion are additional data indicating
that brown adipocytes and skeletal muscle cells share many com-
mon features: an abundance of mitochondria, energy expendi-
ture via oxidative phosphorylation, and sympathetically mediated
adaptive thermogenesis.
In a recent study by Gilsanz et al. (2011) young patients with
metabolically active BAT on PET/CT examinations were observed
to have signiﬁcantly greater muscle volume than patients of the
same age and body-mass-index with no visibly identiﬁable BAT
on PET/CT. This ﬁnding was present in the axial and appendicu-
lar skeletons of bothmale and female patients. Gilsanz et al. (2011)
reported that on average, pediatric cancer patients who exhibited
visually evident BAT on their PET/CT exams had approximately
50% greater neck volume and approximately 33% greater gluteal
muscle volume thanpatientswhodidnot exhibit BATFDGuptake.
Figure 3 summarizes some additional results from that study.
Lastly, studies in adults have consistently shown an inverse
relation between body mass, body fat, and BAT (van Marken
Lichtenbelt et al., 2009; Yoneshiro et al., 2011). However, since
BAT decreases while WAT increases with age, attempts to make
an unequivocal connection between these two age dependent tis-
sues has been difﬁcult. Establishing whether increased obesity is
inversely associated with BAT in normal pediatric populations can
have important implications that can lead to potential strategies
to combat obesity and its comorbidities (Lee et al., 2011).
FIGURE 3 | Scatter plot of muscle volume versus age for male and
female pediatric patients with (black, BAT+) and without (gray, BAT−)
visually depicted metabolically active BAT by PET/CT. For males
without visualized BAT (gray triangles), the linear correlation coefﬁcient was
r =0.88; for males with visualized BAT (black triangles), the coefﬁcient was
r =0.72; for females without visualized BAT (gray circles), the coefﬁcient
was r =0.85; for females with visualized BAT (black circles), the coefﬁcient
was r =0.78. All correlations were statistically signiﬁcant with p<0.001.
SUMMARY
With the resurgent discovery of human BAT by PET/CT, new fron-
tiers are now being pursued to study the modulation of this tissue
during human growth and development and its involvement in
regulating body metabolism, energy expenditure and body com-
position, especially in children and adolescents. These issues are
of high relevance to public healthcare as the obesity epidemic
affecting all ages across Western countries continues to spread.
MRI represents the most suitable non-invasive imaging modality
to overcome the limitations of PET/CT. MRI methods that can
detect BAT based on intrinsic tissue morphology are minimally
susceptible to environmental and extraneous confounding factors
that have thus far restricted functional PET/CT. The demonstra-
tion of feasibility in employing such MRI methods in humans,
particularly in pediatrics, will be the next major advancement.
Progress in knowledge of human BAT physiology will come from
MRI methodological developments that will allow the identiﬁca-
tion and quantiﬁcation of both metabolically active and inactive
BAT with high sensitivity and speciﬁcity.
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